Universal DX
Universal DX is a medical technology company focused on developing next-generation blood-based early cancer detection tests. The company combines advanced genomics, machine learning, and proprietary computational biology to identify multiple cancer types from a single liquid biopsy sample, aiming to significantly improve early-stage cancer diagnosis and patient outcomes. It is a young, research-driven MedTech scale-up operating globally.
Company History
Founded in 2017 in Spain, Universal DX emerged from a vision to use genomics and artificial intelligence to enable early cancer detection through a simple blood test. The company has developed and validated its platform, pursued clinical studies, and expanded internationally while maintaining its scientific and operational base in Seville.
For International Professionals
- The company is headquartered in Seville, a city with a smaller but growing tech scene, offering a lighter relocation profile than Madrid or Barcelona.
- International hires are welcomed, and English is commonly used in the workplace, reflecting its global ambitions.
- You'll work at the intersection of cutting-edge AI and biomarker research with a clear mission to improve cancer survival.
- The company is backed by significant funding (e.g., a $25M Series A round) aimed at operational growth, which may translate into early-stage career opportunities after relocation.
- Working hours are typically flexible, and the company fosters an interdisciplinary environment where to innovate in liquid biopsy.
Open Positions (0)
No open positions right now. Check back soon!
Browse all jobs